5 pending office actions • 1 client
| Client (Assignee) | Pending OAs |
|---|---|
| Allogene Therapeutics, Inc. | 5 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18450554 | METHOD FOR INHIBITING ADVENTITIOUS VIRAL INFECTION | Allogene Therapeutics, Inc. | PENNINGTON, HALLIE NICOLE | 1671 | Non-Final OA | Aug 16, 2023 |
| 18365014 | CHIMERIC CYTOKINE RECEPTORS BEARING A PD-1 ECTODOMAIN | Allogene Therapeutics, Inc. | SANG, HONG | 1646 | Non-Final OA | Aug 03, 2023 |
| 17550311 | METHODS AND REAGENTS FOR CHARACTERIZING CAR T CELLS FOR THERAPIES | Allogene Therapeutics, Inc. | SPENCE, JENNIFER SUZANNE | 1633 | Final Rejection | Dec 14, 2021 |
| 16826102 | METHODS FOR ENHANCING TCRab+ CELL DEPLETION EFFICIENCY | Allogene Therapeutics, Inc. | DHAR, MATASHA | 1632 | Non-Final OA | Mar 20, 2020 |
| 16695894 | CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN AND METHODS OF USE THEREOF | Allogene Therapeutics, Inc. | HALVORSON, MARK | 1646 | Non-Final OA | Nov 26, 2019 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial